SCHEMBL30356598

SCHEMBL30356598

c1ccc2c(c1)ccc1c3ncncc3oc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.42
CYP1A1 P04798 5/20 0.42
CYP1B1 Q16678 5/20 0.42
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 5/20 0.40
KMT2A Q03164 2/20 0.40
PRKDC P78527 2/20 0.40
POLB P06746 1/20 0.40
CFTR P13569 1/20 0.40
LIMK1 P53667 1/20 0.40
HPGD P15428 7/20 0.37
ALDH1A1 P00352 6/20 0.37
MAPT P10636 5/20 0.37
HSD17B10 Q99714 2/20 0.37
HTT P42858 2/20 0.37
ALOX15 P16050 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22483141 1.00 CYP1A2 (0.42) CYP1A2CYP1A1CYP1B1CYP2C9CYP2C19
SCHEMBL30075707 0.79 AHR (0.43) CYP1A2CYP1A1CYP2C9CYP2C19NPC1
SCHEMBL22476343 0.79 AHR (0.43) CYP1A2CYP1A1CYP2C9CYP2C19NPC1
SCHEMBL21030536 0.78 CYP1A2 (0.47) CYP1A2CYP1A1CYP1B1CYP2C9CYP2C19
SCHEMBL483929 0.76 SMN1; SMN2 (0.51) CYP1A2CYP2C9CYP2C19NPC1RAB9A
SCHEMBL21398140 0.76 SMN1; SMN2 (0.38) CYP1A2CYP2C9CYP2C19NPC1RAB9A
SCHEMBL13509564 0.76 SMN1; SMN2 (0.38) CYP1A2NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL24958331 0.76 CYP1A1 (0.44) CYP1A2CYP1A1CYP1B1CYP2C9CYP2C19
SCHEMBL19758245 0.75 SMN1; SMN2 (0.47) CYP1A2CYP2C9CYP2C19NPC1RAB9A
SCHEMBL18852808 0.75 MAPT (0.51) CYP1A2CYP1A1CYP1B1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12232420-B2 Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-02-18 US disclosed
US-20230112454-A1 ORGANIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12232420-B2 Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device CCNE2, AOX1, CCNE1 CYP1A2 130/4885CYP1A1 19/4885CYP1B1 78/4885
US-20230112454-A1 ORGANIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE CCNE2, AOX1, CCNE1 CYP1A2 130/4885CYP1A1 19/4885CYP1B1 78/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.